BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38753562)

  • 1. Drosophila in the study of hTBP protein interactions in the development and modeling of SCA17.
    Montalvo-Méndez RJ; Cárdenas-Tueme M; Reséndez-Pérez D
    Gac Med Mex; 2024; 160(1):1-8. PubMed ID: 38753562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome.
    Ren J; Jegga AG; Zhang M; Deng J; Liu J; Gordon CB; Aronow BJ; Lu LJ; Zhang B; Ma J
    Hum Mol Genet; 2011 Sep; 20(17):3424-36. PubMed ID: 21653638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of TBP contributes to SCA17 pathogenesis.
    Hsu TC; Wang CK; Yang CY; Lee LC; Hsieh-Li HM; Ro LS; Chen CM; Lee-Chen GJ; Su MT
    Hum Mol Genet; 2014 Dec; 23(25):6878-93. PubMed ID: 25104854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17.
    Chang YC; Lin CY; Hsu CM; Lin HC; Chen YH; Lee-Chen GJ; Su MT; Ro LS; Chen CM; Hsieh-Li HM
    J Neurochem; 2011 Jul; 118(2):288-303. PubMed ID: 21554323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms and Therapeutics for SCA17.
    Liu Q; Pan Y; Li XJ; Li S
    Neurotherapeutics; 2019 Oct; 16(4):1097-1105. PubMed ID: 31317427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar Ataxia Type 17 (SCA17).
    Toyoshima Y; Takahashi H
    Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.
    Huang S; Yang S; Guo J; Yan S; Gaertig MA; Li S; Li XJ
    Cell Rep; 2015 Oct; 13(1):196-208. PubMed ID: 26387956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic defects from the expression of wild-type and pathogenic TATA-binding proteins in new Drosophila models of Spinocerebellar Ataxia Type 17.
    Patel N; Alam N; Libohova K; Dulay R; Todi SV; Sujkowski A
    G3 (Bethesda); 2023 Sep; 13(10):. PubMed ID: 37551423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically modified rodent models of SCA17.
    Cui Y; Yang S; Li XJ; Li S
    J Neurosci Res; 2017 Aug; 95(8):1540-1547. PubMed ID: 27859490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.
    Kelp A; Koeppen AH; Petrasch-Parwez E; Calaminus C; Bauer C; Portal E; Yu-Taeger L; Pichler B; Bauer P; Riess O; Nguyen HP
    J Neurosci; 2013 May; 33(21):9068-81. PubMed ID: 23699518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.
    Zühlke C; Dalski A; Schwinger E; Finckh U
    BMC Med Genet; 2005 Jul; 6():27. PubMed ID: 15989694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
    Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
    Shah AG; Friedman MJ; Huang S; Roberts M; Li XJ; Li S
    Hum Mol Genet; 2009 Nov; 18(21):4141-52. PubMed ID: 19643914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK activation precedes Purkinje cell loss in mice with Spinocerebellar ataxia type 17.
    Lin CW; Fan CH; Chang YC; Hsieh-Li HM
    Neurosci Lett; 2020 Nov; 738():135337. PubMed ID: 32877710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17.
    Liu Q; Huang S; Yin P; Yang S; Zhang J; Jing L; Cheng S; Tang B; Li XJ; Pan Y; Li S
    Nat Commun; 2020 Feb; 11(1):1101. PubMed ID: 32107387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).
    Prigge JR; Schmidt EE
    BMC Mol Biol; 2007 Sep; 8():76. PubMed ID: 17868456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
    Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models.
    Chen CM; Chen WL; Hung CT; Lin TH; Lee MC; Chen IC; Lin CH; Chao CY; Wu YR; Chang KH; Hsieh-Li HM; Lee-Chen GJ
    Aging (Albany NY); 2019 Feb; 11(3):986-1007. PubMed ID: 30760647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advance in research on spinocerebellar ataxia 17].
    Zhang J; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.